Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UT Southwestern’s Beth Levine Elected to National Academy of Sciences

Published: Monday, July 29, 2013
Last Updated: Monday, July 29, 2013
Bookmark and Share
Dr. Beth Levine is the professor of internal medicine and microbiology at UT Southwestern Medical Center.

The National Academy of Sciences has announced the election of Dr. Beth Levine, professor of internal medicine and microbiology, and a Howard Hughes Medical Institute (HHMI) investigator at UT Southwestern Medical Center, to membership, representing one of the highest honors attainable by an American scientist.

With Dr. Levine’s election, UT Southwestern now has 20 members of this prestigious society among its faculty, a distinction that places UT Southwestern among the very best academic medical centers in the country.

“I am thrilled to be acknowledged by my fellow researchers with such a prestigious honor. I am extremely appreciative to those who have supported me along the way and for all those who have helped contribute to the scientific discoveries in our lab,” said Dr. Levine, who directs the Center for Autophagy Research in Internal Medicine and who holds the Charles Cameron Sprague Distinguished Chair in Biomedical Science.

Dr. Levine continued, “Most of all, I appreciate the freedom I have enjoyed throughout my career to pursue new scientific ideas - as this freedom has been at the root of our discoveries. We hope to use our discoveries to improve the prevention and treatment of human disease.”

Dr. Levine’s research explores a cellular process called autophagy, in which cells devour their own damaged or unneeded components. Her laboratory identified the first known gene in mammals that is responsible for autophagy.

Her research has since shown that defects in the expression or function of this specific gene, called beclin 1, may contribute to cancer, aging, neurodegenerative diseases such as Alzheimer’s, and infectious diseases. Conversely, beclin 1 activity and the autophagy pathway appear to be important for protection against breast, lung, ovarian, and perhaps other cancers, as well as for fighting off viral and bacterial infections, and protecting individuals from neurodegenerative diseases and aging.

Dr. Levine’s current research focuses on the role of autophagy in normal development and control of lifespan, the mechanisms by which autophagy genes suppress tumors, the biochemical mechanisms that regulate beclin 1 function, and the role of autophagy as a defense mechanism against certain viruses and bacteria.

“Dr. Levine’s groundbreaking work has identified fundamental biological pathways with broad importance for understanding the pathogenesis of many of the most significant disease challenges of our time,” said Dr. Daniel K. Podolsky, president of UT Southwestern. “This award is a well-deserved acknowledgement of her accomplishments and another shining example of the strength of UT Southwestern’s research community.”

Dr. Levine received her medical degree from Cornell University Medical College. She completed her residency at Mount Sinai Hospital, followed by a postdoctoral fellowship in infectious diseases at Johns Hopkins Hospital.

She was a faculty member at Columbia University College of Physicians and Surgeons before joining the UT Southwestern faculty in July 2004.

A recipient of the American Cancer Society TIAA-CREF Award for Outstanding Achievements in Cancer Research, Dr. Levine was elected to membership in the American Society of Clinical Investigation in 2000 and the Association of American Physicians in 2006.

“This is terrific news. Beth is an extraordinary physician scientist, and her work in autophagy has defined an entirely new area that has fundamental importance across medicine and biology. This election is so well deserved, and I think the best is yet to come,” said Dr. J. Gregory Fitz, executive vice president for academic affairs, provost, and dean of UT Southwestern Medical School.

In 2008, Dr. Levine received one of four Edith and Peter O’Donnell Awards from The Academy of Medicine, Engineering and Science of Texas (TAMEST). The annual award honors researchers in science, medicine, engineering, and technology innovation whose work seems destined for international prominence at the highest level.

“Beth is justly deserving of this latest honor based on her remarkable scientific achievements. She is such an amazing mentor and a superb role model for our young physician-scientists. We are incredibly proud to have her as a colleague in medicine,” said Dr. David Johnson, chairman of internal medicine.

In all, the NAS announced the election of 84 new members and 21 foreign associates. One other new member is from a Texas institution, which makes for a total of 31 NAS members at Texas academic medical centers, almost two-thirds of them at UT Southwestern.

The election of new NAS members was announced during the 150th annual meeting of the academy in Washington, D.C. The NAS is a private, nonprofit society of distinguished scholars engaged in scientific and engineering research.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cell that Replenishes Heart Muscle Found by UT Southwestern Researchers
Researchers devise a new cell-tracing technique to detect cells that do replenish themselves.
Tuesday, June 23, 2015
Researchers Find Molecular Mechanisms within Fetal Lungs that Initiate Labor
Biochemists found that steroid receptor coactivators 1 and 2 (SRC-1 and SRC-2) proteins control genes.
Tuesday, June 23, 2015
Researchers Discover Molecule that Accelerates Tissue Regeneration
Newly discovered molecule, SW033291 accelerate cell recovery following bone marrow transplants.
Friday, June 12, 2015
Mutations in Two Genes Linked to Familial Pulmonary Fibrosis and Telomere Shortening
PARN and RTEL1 genes strengthen the link between lung fibrosis and telomere dysfunction.
Tuesday, May 05, 2015
Scientists Identify Key Receptors Behind Development of AML
Blocking ITIM-receptor signaling in combination with conventional therapies may represent a novel strategy for AML treatment.
Saturday, May 02, 2015
Study Reveals Molecular Genetic Mechanisms Driving Breast Cancer Progression
The findings are published online and in the journal Molecular Cell.
Saturday, April 04, 2015
New Cyclotron Facility at UT Southwestern
Expands research opportunities and imaging capabilities for detecting, tracking cancer.
Friday, March 20, 2015
Acetate Supplements Shown to Speed Up Cancer Growth
A major compound produced in the gut by host bacteria.
Friday, February 20, 2015
MAGE Genes Provide Insight into Optimizing Chemotherapy
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
Tuesday, February 17, 2015
Researchers Identify ‘Achilles heel’ in Metabolic Pathway
Achilles heel could lead to new lung cancer treatments.
Saturday, February 14, 2015
Study Links Deficiency of Cellular Housekeeping Gene with Aggressive Forms of Breast Cancer
Research team studies genes involved in the autophagy process and their roles in cancer, aging, infections, and neurodegenerative diseases.
Saturday, January 31, 2015
Targeting The Cell’s ‘Biological Clock’
Researchers target the cell’s ‘biological clock’ in promising new therapy to kill cancer cells, shrink tumor growth.
Monday, January 05, 2015
Whole-Genome Sequencing Successfully Identifies Cancer-Related Mutations
UT Southwestern Medical Center cancer researchers have demonstrated that whole-genome sequencing can be used to identify patients’ risk for hereditary cancer.
Wednesday, December 24, 2014
Therapeutic Strategy May Treat a Childhood Neurological Disorder
Researchers have identified a possible therapy to treat neurofibromatosis type 1 or NF1.
Wednesday, December 17, 2014
Signaling Mechanism Could Be Target For Survival, Growth Of Tumor Cells In Brain Cancer
Non-canonical EGFR signalling shown to make glioblastoma tumor cells more resistant to chemotherapy treatment.
Monday, December 15, 2014
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!